Amanda E. Seitz

Experience

• Represented an investment adviser in an SEC enforcement proceeding related to disclosure and risk control issues.
• Advised a private equity client in analyzing potential Securities Act violations and remedies, including rescission.
• Representing a global pharmaceutical company in litigation in the Northern District of California asserting claims under the Lanham Act against competitors' false and misleading marketing of unapproved drug products as FDA-approved generics for client's NDA-approved prescription drug.
• Representing a global pharmaceutical company in DOJ investigation concerning alleged violations of the False Claims Act and FDA Good Manufacturing Practices.
• Assisting private equity sponsors and their portfolio companies to identify, assess, and mitigate corruption, sanctions, and money-laundering risks related to various transactions and investments, including subsequent compliance monitoring of acquired portfolio companies and compliance program uplifts.
• Assisting private equity sponsors and their portfolio companies to identify, assess, and mitigate litigation risks related to various transactions and investments.
• Representing private equity sponsor in post-closing dispute involving representations and warranties, fraud, insurance coverage, and other deal-related issues.
• Representing a global agricultural company in conducting an internal investigation into accounting and trading issues after external auditors’ receipt of a whistleblower complaint.
• Conducted investigation on behalf of a large non-profit hospital group into allegations of financial fraud by former chief executive officer.
• Represented medical device supplier in internal investigation relating to Medicare billing requirements and adequacy of compliance controls.
• Represented a global company in connection with an anti-corruption and ethics focused risk assessment.
• Represented three mutual fund investment advisers against claims of excessive fees under Section 36(b) of the Investment Company Act of 1940.
• Advising a European-based life sciences company in assessing and mitigating its U.S. corruption and regulatory risk.
• Conducted an internal investigation for a global oil and gas company regarding potential FCPA violations.
• Part of trial team that represented plaintiffs in a class action lawsuit against a state-run juvenile treatment facility, alleging violations of the Eighth and Fourteen Amendments arising out of excessive and punitive use of solitary confinement and fixed mechanical restraints. Ropes & Gray, along with co-counsel Children's Rights and Disability Rights Iowa, litigated the case through a two-week trial in federal court, securing sweeping injunctive relief under the Fourteenth Amendment and the appointment of a monitor. Team was awarded firm-wide 2020 Pro Bono Team Award.
• Obtained asylum for Angolan man persecuted on account of his ethnic group and/or imputed nationality in immigration court.